Enrichment Markers in Clinical Trials David H. Millis, MD, MBA, PhD Medical Officer, Division of
Machine-Learning-Derived Enrichment Markers in Clinical Trials David H. Millis, MD, MBA, PhD Medical Officer, Division of Psychiatry Center for Drug Evaluation and Research U.S. Food and Drug Administration February 20, 2020 Disclaimers This
549 views • 28 slides